Group One Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,100
| Closed | -$1.17K | – | 8198 |
|
|
2022
Q4 | $1.17K | Hold |
2,100
| – | – | ﹤0.01% | 6795 |
|
|
2022
Q3 | $3K | Buy |
2,100
+700
| +50% | +$755 | ﹤0.01% | 7083 |
|
|
2022
Q2 | $1K | Sell |
1,400
-100
| -7% | -$77 | ﹤0.01% | 7672 |
|
|
2022
Q1 | $2K | Sell |
1,500
-6,200
| -81% | -$7.41K | ﹤0.01% | 7773 |
|
|
2021
Q4 | $17K | Sell |
7,700
-76,500
| -91% | -$192K | ﹤0.01% | 7087 |
|
|
2021
Q3 | $288K | Buy |
84,200
+27,400
| +48% | +$84.5K | ﹤0.01% | 4793 |
|
|
2021
Q2 | $170K | Buy |
56,800
+3,400
| +6% | +$10.8K | ﹤0.01% | 5408 |
|
|
2021
Q1 | $172K | Buy |
53,400
+45,800
| +603% | +$153K | ﹤0.01% | 5178 |
|
|
2020
Q4 | $16K | Buy |
+7,600
| New | +$12.5K | ﹤0.01% | 5630 |
|
|
2019
Q3 | – | Sell |
-3,500
| Closed | -$6K | – | 5690 |
|
|
2019
Q2 | $6K | Hold |
3,500
| – | – | ﹤0.01% | 4578 |
|
|
2019
Q1 | $7K | Sell |
3,500
-4,200
| -55% | -$6.14K | ﹤0.01% | 4381 |
|
|
2018
Q4 | $9K | Sell |
7,700
-7,200
| -48% | -$12.9K | ﹤0.01% | 4318 |
|
|
2018
Q3 | $40K | Sell |
14,900
-4,100
| -22% | -$8.48K | ﹤0.01% | 4097 |
|
|
2018
Q2 | $36K | Buy |
19,000
+5,200
| +38% | +$10.5K | ﹤0.01% | 4123 |
|
|
2018
Q1 | $29K | Sell |
13,800
-15,200
| -52% | -$32.6K | ﹤0.01% | 3935 |
|
|
2017
Q4 | $59K | Sell |
29,000
-19,200
| -40% | -$39.8K | ﹤0.01% | 3643 |
|
|
2017
Q3 | $64K | Buy |
48,200
+46,500
| +2,735% | +$57.7K | ﹤0.01% | 3505 |
|
|
2017
Q2 | $3K | Buy |
+1,700
| New | +$3.28K | ﹤0.01% | 4531 |
|
|
2017
Q1 | – | Sell |
-182,800
| Closed | -$247K | – | 5115 |
|
|
2016
Q4 | $247K | Buy |
182,800
+70,300
| +62% | +$91.8K | ﹤0.01% | 2276 |
|
|
2016
Q3 | $176K | Buy |
+112,500
| New | +$173K | ﹤0.01% | 2553 |
|
|
2016
Q1 | – | Sell |
-34,800
| Closed | -$273K | – | 5065 |
|
|
2015
Q4 | $273K | Sell |
34,800
-11,600
| -25% | -$99.9K | ﹤0.01% | 2260 |
|
|
2015
Q3 | $392K | Sell |
46,400
-6,700
| -13% | -$61.8K | 0.01% | 1977 |
|
|
2015
Q2 | $581K | Sell |
53,100
-2,000
| -4% | -$25.7K | 0.01% | 1647 |
|
|
2015
Q1 | $770K | Sell |
55,100
-44,500
| -45% | -$680K | 0.01% | 1278 |
|
|
2014
Q4 | $1.68M | Sell |
99,600
-27,100
| -21% | -$395K | 0.03% | 747 |
|
|
2014
Q3 | $1.7M | Buy |
126,700
+28,000
| +28% | +$333K | 0.03% | 783 |
|
|
2014
Q2 | $1.26M | Sell |
98,700
-45,700
| -32% | -$476K | 0.02% | 983 |
|
|
2014
Q1 | $1.72M | Sell |
144,400
-137,100
| -49% | -$1.84M | 0.03% | 708 |
|
|
2013
Q4 | $3.89M | Buy |
281,500
+207,000
| +278% | +$2.92M | 0.06% | 341 |
|
|
2013
Q3 | $1.3M | Buy |
74,500
+2,700
| +4% | +$51.7K | 0.02% | 811 |
|
|
2013
Q2 | $1.17M | Buy |
+71,800
| New | +$2.22M | 0.03% | 711 |
|
Other funds holding INFI
Group One Trading's INFI Position: Q3 2023 in Review
Group One Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 14,150 shares — an estimated $2.98K sold.
Group One Trading first reported a position in INFI in Q2 2013 and held it in 36 quarters. The position peaked at $3.04M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Group One Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Group One Trading sold 14,150 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.98K.
- Group One Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
- Group One Trading's Infinity Pharmaceuticals, Inc. position peaked at $3.04M in Q4 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.